Abstract: A maintenance prioritization method, system, and computer program product, include collecting information including image data and status data for a plurality of objects of interest, building a three-dimensional image for each object, and estimating a risk factor of failure for each object by analyzing the information and the three-dimensional image of the object to compare with known characteristics of the object and a reference object description.

Abstract: A table device for a seat, in particular for an aircraft seat, includes a table unit which is configured for being adjustable at least between a use position and a stowage position, and has at least one locking module which has at least one attachment unit which is configured for being at least in part fixedly connected to a seat component, wherein the table unit at least in the stowage position is lockable to the attachment unit. The locking module has at least two force-fit and/or form-fit elements, by means of which the table unit in a locked state is coupled in a form-fitting and/or force-fitting manner to the attachment unit.

Abstract: Tourniquets have an elongated body having opposed first and second anchor locations, a strap having a body end connected to and extending from the first anchor location of the body, the strap having a free end, the second anchor location of the body having an adjustor buckle defining a passage receiving an intermediate portion of the strap between the body end and the free end, the adjustor buckle configured to resist movement of the strap through the passage in response to tension applied between the body and the portion of the strap extending toward the body end, and to enable movement of the strap through the passage in response to tension applied between the elongated body and a tail portion of the strap extending from the intermediate portion to the free end, the elongated body having a tightener, and the tail portion being connected to the elongated body.

Abstract: The present invention relates to a conjugate or a pharmaceutically acceptable salt thereof comprising an GLP-1/Glucagon receptor agonist, a linker and a hyaluronic acid hydrogel bearing -L1-L2-L-L-Y—R20 groups, wherein Y represents an GLP-1/Glucagon receptor agonist moiety; and -L is a linker moiety—by formula (Ia), wherein the dashed line indicates the attachment to one of the amino groups of the GLP-1/Glucagon receptor agonist moiety by forming an amide bond. The invention further relates to pharmaceutical compositions comprising the conjugate or the pharmaceutically acceptable salt thereof as well as their use as a medicament for treating or preventing diseases or disorders which can be treated by GLP-1/Glucagon receptor agonist.

Abstract: A luminaire adapted to apply an auto-gradient effect across pixels has an interface coupled by a connection to a controller. The controller has electronic circuitry that receives a predetermined start light parameter for a start pixel of a luminaire and receives a predetermined end light parameter for an end pixel of the first luminaire, the predetermined end light parameter greater than the predetermined start light parameter. The controller circuitry then automatically interpolates a gradient effect for a middle light parameter of each of a plurality of middle pixels of the luminaire based on the start and end predetermined light parameters. The controller circuitry then outputs control signals having the start, end and middle light parameters to the start, end and middle light pixels, respectively, through the connection and to the interface.

Abstract: Examples provide a wideband filter structure and apparatus, a radio transceiver, a mobile terminal, and a method for filtering a radio signal. The wideband filter structure (10) for a radio signal comprises a combination of at least one acoustic resonator (12) and at least one analog resonator (14). The acoustic resonator (12) is coupled to the analog resonator (14). The wideband filter structure (10) comprises a further component (16), which is coupled to the combination of the acoustic resonator (12) and the analog resonator (14).

Abstract: The present invention relates to exendin-4 peptide analogues which selectively bind and activate the glucagon receptor and comprise a chelating moiety capable of binding a metal ion and their use, for example in PET imaging.

Abstract: A security system for a building has multiple lock modules. Each lock module is associated with a particular door and has an unlocked position that allows the particular door to open and a locked position that prevents the particular door from opening. Each lock module includes a door status signal and a controller. The door status signal includes a unique identifier for the particular door associated with the lock module and a status that identifies when the lock module is in the locked position. The controller transmits the door status signal for the lock module. A lock module command signal received by at least some of the lock modules directs at least some of the lock modules to reposition to either the unlocked position or the locked position.

Abstract: A security system for a building includes a plurality of lock modules. Each lock module is associated with a particular door and has an unlocked position and a locked position. Each lock module includes a lock bar, an actuator, and a controller. The lock bar has a first position that allows the particular door to open and a second position that extends from a door frame, a wall, or a floor surface adjacent to the particular door to prevent the particular door from opening. The actuator moves the lock bar between the first and second positions. The controller is operably connected to the actuator and transmits a door status signal that uniquely identifies the particular door. A lock module command signal received by the plurality of lock modules directs the plurality of lock modules to reposition to either the unlocked position or the locked position.

Abstract: A security system for a building has multiple lock modules. Each lock module is associated with a particular door and has an unlocked position that allows the particular door to open and a locked position that prevents the particular door from opening. Each lock module includes a door status signal and a controller. The door status signal includes a unique identifier for the particular door associated with the lock module and a status that identifies when the lock module is in the locked position. The controller transmits the door status signal for the lock module. A lock module command signal received by at least some of the lock modules directs at least some of the lock modules to reposition to either the unlocked position or the locked position.

Abstract: According to some embodiments, an organic device and method of forming an organic device are disclosed. A hybrid cathode layer is formed in stacked alignment with a substrate. The hybrid cathode layer includes a combination of a conductive nanowire and an electron-transport material. After forming the hybrid cathode layer, a photoactive layer is formed on a structure that includes the substrate and the hybrid cathode layer. After forming the photoactive layer, a hybrid anode layer that is separated from the hybrid cathode layer by the photoactive layer is formed. The hybrid anode layer includes a combination of a conductive nanowire and a hole-transporting material.

Abstract: The present invention relates to a prodrug or a pharmaceutically acceptable salt thereof comprising an GLP-1/Glucagon agonist linker conjugate Z-L1-L2-L-Y—R20, wherein Y represents an GLP-1/Glucagon agonist moiety; and -L is a linker moiety—by formula (Ia), wherein the dashed line indicates the attachment to one of the amino groups of the GLP-1/Glucagon agonist moiety by forming an amide bond. The invention further relates to pharmaceutical compositions comprising said prodrugs as well as their use as a medicament for treating or preventing diseases or disorders which can be treated by GLP-1/Glucagon agonist.

Abstract: The present invention relates to a conjugate or a pharmaceutically acceptable salt thereof comprising an GLP-1/Glucagon receptor agonist, a linker and a hyaluronic acid hydrogel bearing -L1-L2-L-Y—R20 groups, wherein Y represents an GLP-1/Glucagon receptor agonist moiety; and -L is a linker moiety—by formula (Ia), wherein the dashed line indicates the attachment to one of the amino groups of the GLP-1/Glucagon receptor agonist moiety by forming an amide bond. The invention further relates to pharmaceutical compositions comprising the conjugates as well as their use as a medicament for treating or preventing diseases or disorders which can be treated by GLP-1/Glucagon receptor agonist.

Abstract: A reality augmenting computer-implemented method, system, and computer program product, includes detecting a consumer and at least one of a product and a location, determining a current sensory state of the consumer, calculating a desired sensory state to achieve a target mood based on a correlation between the target mood and a user model, and executing an action according to the desired sensory state by a wearable to change the current sensory state of the consumer to the target mood.

Abstract: System and method configured to determine a direction of movement of a vehicle in response to a brake being released or in response to initiating movement of the vehicle from a stopped position along a route. The direction of movement is determined based on a selected travel direction of the vehicle, a grade of the route, and at least one of applied tractive efforts or applied braking efforts.

Abstract: A modular switching network node for a communications network, i.e., an industrial communications network, where the modular switching network node comprises a switching network node base unit and at least one port module, the at least one port module comprises at least one connection interface for coupling to the communications network, and where the modular switching network node is configured to forward communication data over one of the connection interfaces of the modular switching network node to at least one additional connection interface of the modular switching network node. The switching network node base unit is configured such that at least one of the port modules is swappable for a functional module to expand the functionality of the switching network node.

Abstract: The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.

Abstract: The present invention relates to exendin-4 peptide analogues which selectively bind and activate the glucagon receptor and comprise a chelating moiety capable of binding a metal ion and their use, for example in PET imaging.

Abstract: A vehicle control system determines an upper non-zero limit on deceleration of a vehicle to prevent rollback of the vehicle down a grade being traveled up on by the vehicle. The upper non-zero limit on deceleration is determined by the controller based on a payload carried by the vehicle, a speed of the vehicle, and a grade of a route being traveled upon by the vehicle. The controller is configured to monitor the deceleration of the vehicle, and to automatically prevent the deceleration of the vehicle from exceeding the upper non-zero limit by controlling one or more of a brake or a motor of the vehicle. The controller also is configured to one or more of actuate the brake or supply current to the motor of the vehicle to prevent rollback of the vehicle while the vehicle is moving up the grade at a non-zero speed.

Abstract: The present invention relates to the medical use of specific GLP-1/glucagon receptor agonists in the prevention and/or treatment of metabolic liver disease, particularly non-alcoholic fatty liver disease (NAFLD), more particularly non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH) and/or NAFLD-associated liver fibrosis.